Results 211 to 220 of about 1,171,600 (244)

Efficacy of RCI001 as a Therapeutic Candidate in a Primary Sjögren Syndrome Mouse Model. [PDF]

open access: yesCornea
Kang H   +7 more
europepmc   +1 more source

[Clinical efficacy and safety of rituximab in treating renal injury in primary Sjögren syndrome]. [PDF]

open access: yesBeijing Da Xue Xue Bao Yi Xue Ban
Zhao Y   +6 more
europepmc   +1 more source

CD8+ T cell depletion promotes human Tph/Tfh cell proliferation and Sjögren syndrome-like symptoms in PBMC-based humanized mice. [PDF]

open access: yesJCI Insight
Piruzyan M   +7 more
europepmc   +1 more source

Clinicopathologic Features and Prognostic Factors in Biopsy-Confirmed Renal Involvement in Primary Sjőgren Syndrome. [PDF]

open access: yesKidney360
Thongprayoon C   +6 more
europepmc   +1 more source

Issue Information

open access: yes
Experimental Physiology, Volume 111, Issue 10, Page 4949-4954, 1 October 2026.
wiley   +1 more source

Exocrine function in primary Sjögren syndrome: natural course and prognostic factors

Annals of the Rheumatic Diseases, 2008
Few studies have addressed the natural course of, or prognostic factors for the salivary and lacrimal function in primary Sjögren syndrome (SS). Except for the early stages, glandular function has been seemingly stable, and SS A antigen (SSA) seropositivity and hypocomplementemia may predict a decline in the van Bijsterveld score.
K, Haldorsen   +4 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy